Suzanne Filippi

Suzanne Filippi


Email suzanne.filippi@​

Phone +1 617 702 7797

Fax +1 617 371 1037

Practice groupCorporate & Finance

Suzanne Filippi focuses her corporate practice on U.S. and international corporate transactions in the life sciences ecosystem. She brings vast experience in both public and private M&A, venture capital, joint ventures, partnerships, collaboration/licensing transactions, and strategic alliances.

Additionally, she regularly advises on general corporate matters such as securities compliance, corporate governance, executive compensation, and a range of other complex issues. Suzanne has a reputation for providing creative, sophisticated, and practical advice to companies facing critical transitions – evolving from clinical to a commercial stage company, going public, exits, the onset of a hyper-growth stage, or resolving financial or regulatory challenges.

Suzanne's legal career began in the M&A practice at a preeminent international law firm in New York and the business law group of a prominent international law firm in Boston, where she represented leading companies in the life sciences, technology, and consumer goods sectors in a wide range of transactional and securities matters.

Before joining Hogan Lovells, Suzanne held VP, Corporate Counsel Consultant roles at clinical and commercial stage biopharmaceutical companies in Cambridge – Sage Therapeutics and Aegerion Pharmaceuticals. She also served as the Senior Securities and M&A Counsel at TripAdvisor, where she spearheaded the company's US$9 billion spin-off and IPO, playing a key role in shaping its best-in-class public company infrastructure.

Education and admissions


J.D., Harvard Law School, 2002

B.A., Rutgers University, 1999

Bar admissions and qualifications


Representative experience

Represented numerous Fortune 500 public biopharmaceutical companies in a variety of licensing, collaboration, and complex commercial transactions.

Represented Alere Inc. (f.k.a. Inverness Medical Innovations, Inc.) on its US$1.68bn hostile tender offer and acquisition of Biosite, Inc., a leader in the medical diagnostic testing industry.*

Represented Avant Immunotherapeutics, Inc. on its US$75m reverse merger of Callisto Merger Corporation, its wholly owned subsidiary, with and into Celldex Therapeutics, Inc.*

Represented Cingular Wireless LLC on its US$41bn acquisition of AT&T Wireless, creating the largest U.S. wireless carrier.*

Represented Goldman Sachs as exclusive financial advisor in numerous IPOs, spin-offs, going privates, and other M&A transactions with an average transaction range between US$1.1bn and US$5bn.*

Represented Merrill Lynch & Co. as exclusive financial advisor to Equity Office Properties Trust on its going-private acquisition by The Blackstone Group for approximately US$39bn.*

Represented Telewest Global Inc. on its US$11bn cross-border merger with NTL Incorporated, creating the largest cable company in the U.K. and Ireland.*

Represented a commercial stage, NASDAQ pharmaceutical company during its evaluation of several potential strategic transactions/alliances for the company's core assets.*

Represented IMCO Recycling Inc. on its US$2bn merger with Commonwealth Industries Inc., creating Aleris International, Inc.*

Represented a Fortune 500 global distillery company during its evaluation of several potential strategic targets in the U.S.*

Represented Vornado Realty Trust on the sale of 20.7% of its stake in AmeriCold Realty Trust, a joint venture with an enterprise value of US$1.5bn, for approximately US$145m.*

Represented Digitas Inc. on its acquisition by Publicis Groupe, via a cross-border cash tender offer for approximately US$1.3bn.*

Represented Royal Philips Electronics on NAVTEQ's US$1.0bn initial public offering.*

Represented Stride Rite Corp. on its acquisition by Collective Brands Inc. (f.k.a. Payless ShoeSource, Inc.) for approximately US$900m.*

Represented Computer Associates International, Inc. on its acquisition of Niku Corporation, in an all-cash merger valued at approximately US$350m.*

Represented Computer Associates International, Inc. on its acquisition of Concord Communications, Inc., in an all-cash merger valued at approximately US$350m.*

Represented Optium Corporation on its US$211m stock-for-stock "merger of equals" with Finisar Corp.*

Represented Clayton Holdings, Inc., on its approximately US$158m going private transaction with Greenfield Partners, LLC.*

Represented a large-cap global travel technology company, as in-house counsel, during its spin-off and IPO from Expedia, Inc., and subsequent M&A and securities transactions.*

Represented Prudential Financial, Inc. on its US$1.26bn cross border acquisition of Skandia U.S. Inc.*

*Matter handled prior to joining Hogan Lovells.

Loading data